Liu NaiShan had explored the “311” working method for family planning by collecting the urine of pregnant women, which was highly emphasized by governments at all levels. The Academy of Social Science reported the working method to the central committee of CPC, the State Council, the National People's Congress and the Chinese People’s Political Consultative Conference in the form of National Academy of Newspaper. Meanwhile, it is advised to spread over the whole nation. The national, provincial and municipal Population and Family Planning Commission, as well as the Municipal Committee of the City Hall in Qingdao have issued the papers for promotion according to that suggestion.
Jiang Zhenghua, the vice-chairman of National People’s Congress, came to visit our company, accompanied by the leaders of the provincial and municipal NPFPC on September 13th, 1995.
In October, 1995, Jiang Zhenghua, the vice-chairman of the National People's Congress, and Zhang Weiqing, the director of NPFPC came to inspect the carrying out of “311” working method and the production of high-quality of HCG. After the inspection, they both gave a high evaluation.
The “311” working method had won a second prize in the National Science and Technology Progress Award on March 24th, 1996, with the first prize absent.
From August 1995 to November 1996, the experts committee of National Population and Family Planning Commission organized the on-the-spot investigations of the carrying out of the “311” working method and the high-tech project of HCG two times for about 22 scientific research institutions, experts and professors of colleges and universities, including the Development Research Center under the State Council, National Science and Technology Commission, the Chinese Academy of Social Sciences, Renmin University of China, Peking University, China’s Aging Research Center, National Family Planning Commission, China's Population Intelligence Research Center and so on. As to the scientific researches, they all give a high evaluation and encouragement.
In May, 1997, Jiang Zhenghua, vice-chairman of National People’s Congress, gave a second visit our company, accompanied by the leaders of the provincial and municipal NPFPC.
In October, 1997, Liu NaiShan attended the conference of International Demography of the Highest Levels held in Beijing —the 23rd international conference on population science, and he was warmly received by Jiang Zhenghua and Peng Peiyun, vice-chairmen of the National People's Congress and Zhang Weiqing, director of the NPFPC.
In March, 1998, Jiang Zhenghua, vice-chairman of National People’s Congress, gave a third visit our company, accompanied by the leaders of the provincial and municipal NPFPC. This time, he came to investigate the top-quality project of birth control ——the production of HCG.
On September 19th, 1999, Jiang Zhenghua, vice-chairman of National People’s Congress, wrote a preface for the book The Road of Science written by Liu Naishan.
That same year, the technical achievements of high-quality of HCG project were identified as “the international advanced” by the experts organized by Qingdao Science and Technology Committee.
In 2000, Kangyuan established a technical research institute of reproductive health and eugenic nurture.
In 2001, Kangyuan successfully completed the merger and acquisition of amino acid plant; Qingdao Kangyuan pharmaceutical co., LTD was founded and granted the pharmaceutical production license. In the same year, the HCG project won a second prize in Qingdao Scientific and Technological Progress Award.
In 2002, Jiang Zhenghua, the vice-chairman of the National People's Congress, inscribed for the company.
In 2004, HCG, HMG, UK and sodium benzoate were qualified with drug registration approval by the State Food and Drug Administration.
Passed the drug certification of GMP in 2005; Kangyuan Pharmaceutical co., LTD was rated as the top hundred private enterprise of science and technology in Qingdao.
Made the first “Five Years Development Program” on 2006; the German Kangyuan Pharmaceutical co., LTD was founded in the same year; Kangyuan Pharmaceutical co., LTD was rated as AAA enterprise by Agricultural Bank of China.
In 2007, Kangyuan Pharmaceutical co., LTD was rated as the most growing enterprise by Shanghai Bio-medicine Association.
In 2008, kangyuan was column for one of the 16 listed companies in Qingdao; Attended a meeting for drug manufacturing enterprise in the State Council; Pass the check of “Anti-doping regulations” ; Donated in the charity event for about 120 000 RMB; Was named as “The integrity unit” by Shanghai biological medicine association; HMG and HCG projects received great attention from government.
In 2009, Kangyuan Pharmaceutical base was started to bulid (Investment of 0.3 billion, cover 200 acres); in 29 July, the main persons in charge of government and other foreign traders sum total more than 200 persons attended the foundation stone laying ceremony; Received “animal use certificate” approved by Shandong association for laboratory animal.
In 2010, almost one hundred leaders of government had a visit to the base of Kangyuan; Was named “Caring donation enterprise”; Accepted “Experimental animal production license”
In 2011, drawn up the second “Development Plan for 5 years”; New manufacturing workshops for HCG,HMG and UK passed national GMP certificate.
In 12 June of 2012, Mr. Jiang Zheng Hua visited our company for the forth time; Almost one hundred leaders of government had a visit to the base of Kangyuan for the second time. Protamine sulfate, trypsin, chymotrypsin, hyaluronidase and UTI were added into the Pharmaceutical Production License.
In January 2013, HCG manufacturing workshop had passed US FDF certificate; In 20 Sep started the first battle for the rights protection; Passed recheck for new high-tech enterprise; Got the national patent for invention of “Preparation Method of Protamine Sulfate”; Had reported about 30 country patents of invention, one of them had been approved.
In 20 march of 2014, started the second battle for the rights protection. Had reported about 65 country patents of invention, nine of them had been approved.
In 2015, passed new national GMP certificate; During the first five years and the second five years, sales proceeds had been increased 7 times than 7 years before.
In 2016, drawn up the third “Five years development plan”; In April, HCG passed US FDA certificate again; Until august, reported about 100 country patents of invention, 21 of them had been approved.